A deadly cough syrup scandal has erupted in India, claiming the lives of numerous children across several states. The toxic concoction, linked to the brand Coldrif, has caused at least 20 deaths in Madhya Pradesh alone, spurring police investigations into potential manslaughter and regulatory failures. Authorities have launched probes into the contaminated product, with reports revealing illegal chemical use and gross violations in production standards. As the death toll continues to rise, states like Kerala and Punjab have banned the cough syrup, while families of victims are demanding justice and compensation. The Indian government is intensifying checks and criminal actions against the pharmaceutical company responsible. Medical experts are raising alarms about the dangers of cough syrups for children under 12, emphasizing the urgent need for systemic reforms in drug safety regulation.